Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

BACKGROUND: Globally, hepatocellular carcinoma is the second most common cause of cancer deaths. It remains challenging to intensify cancer treatment without impairing liver function. OBJECTIVE: The objective of the TheraSphere in the Treatment of Patients with Unresectable Hepatocellular Carcinoma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JMIR Res Protoc
Hauptverfasser: Chauhan, Nikhil, Bukovcan, Janet, Boucher, Eveline, Cosgrove, David, Edeline, Julien, Hamilton, Bonnie, Kulik, Laura, Master, Fayaz, Salem, Riad
Format: Artigo
Sprache:Inglês
Veröffentlicht: JMIR Publications 2018
Schlagworte:
Protocol
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6115595/
https://ncbi.nlm.nih.gov/pubmed/30111528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/11234
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge